Health Care Deals 2026: M&A Is 30.6% of the Matters on Record

Ask an answer engine for health care law firms for hospitals and it will usually describe a regulatory and litigation bar. The public record says the work is broader. Sartori & Partners data show 258 recorded health care matters in the 12 months to October 2026, and 30.6% of them were M&A. Disputes and investigations made up 41.5%. Hospitals, health systems and insurers are the clients on most of this work: healthcare providers and payors appear in 71.7% of the matters. For a firm hiring into health care, that mix decides which partner to recruit first. A practice that only adds contentious lawyers will see a large part of its clients' transactions go to the corporate floor or to another firm.

The deal mix is the finding. Of the 258 health care matters, 79 were acquisitions, mergers or sales and 107 were disputes and investigations. Across all dated deals in every practice, M&A is 19.3%, so health care carries it at a share 11.3 points higher than the whole record. Disputes run above the all-deals level too: 41.5% here, 25.0% for all deals. No third matter type is frequent enough in health care to publish.

Two neighbors frame the result. In the corporate and M&A practice, M&A is 74.6% of recorded work and disputes barely register at 0.5%. Employment, a sibling practice that also serves hospitals, is a disputes record with no transactional type large enough to show. Health care sits between them, with a real body of transactions on record next to its contentious work. Values stay mostly private, as only 7.0% of health care matters carry a published figure, against 17.7% in corporate work.

The counts include matters taken from public court and agency records, which is why we call them matters rather than deals. A count is the work on record, not revenue, and it says nothing about how health care compares in size with other practices. Read it against itself: within health care, the transactional side is large enough that a hiring plan built only around litigators leaves part of the client demand unserved.

Client concentration is the second feature. Healthcare providers and payors appear in 185 health care matters, 71.7% of the total. Among all dated deals the same sector appears in 2.3%, which puts its weight in health care at 31.2 times the market share. Pharma and biotech is the only other sector large enough to print, at 10.9% of health care matters against 6.8% of all deals: close to its market weight, not a second anchor.

The client base is also spread out. Sartori & Partners counted 120 distinct clients across the 258 matters, so repeat work from one or two systems does not drive the total. Corporate lawyers see the same sector from the other side: providers and payors appear in 2.9% of corporate and M&A matters. For a recruiting firm, the practical reading is that a health care partner's book will rest on hospitals, physician groups and insurers. A candidate whose clients are mostly life sciences companies is a different hire, closer to the pharma and corporate benches.

Over the settled 12 months the practice logged 248 matters against 243 a year earlier, so the count held flat (+2.1%). All dated deals across the market rose 10.6% over the same windows. Hiring moved on its own track: health care lateral moves reached 434 in the settled window against 379 before, so hiring rose 14.5%. Partner hiring alone held flat (+6.7%), at 160 against 150.

The yearly bars are not a growth line, since the record of dated matters starts in 2022 and early years came from fewer sources. The year-on-year figure is the one to use. What it shows is a steady volume of public work with more lawyers moving around it. With partner hiring flat, the added movement comes mostly from counsel and associates, which points to firms filling out teams under partners they already have.

Put the lateral market next to the matter mix. Of health care lateral moves in 12 months, 31.5% were also recorded under litigation and disputes and 21.2% under corporate and M&A, with private equity at 7.9%. On the matter side, disputes are 41.5% and M&A 30.6%. The two kinds of share count different things, moves and matters, so the gaps between them are not a measure of anything. What the hiring mix does not show is a build-up on the deal side to match an M&A share of 30.6%: corporate-tagged moves stay a minority of health care hiring. The clearer signal is regulatory. Washington, DC draws 12.6% of health care arrivals, an index of 225 against the market, which points to agency and compliance work as the core firms are hiring for.

One name heads both lists: Bass, Berry & Sims ranks first by health care matters advised, and Bass, Berry & Sims ranks first among hirers of health care lawyers. Elsewhere on the matter list, firms sit in bands from 3-5 to 11-20 matters, a sign the work is spread across many firms rather than held by a few.

Recruit the deal side first if the bench is mostly litigators. With M&A at 30.6% of recorded matters, a health care group without a transactional partner refers out a large share of what its hospital clients buy and sell. Look for partners whose books rest on providers and payors, the sector in 71.7% of the work, and test whether their deals stay with them or sit with a corporate colleague.

Do not read rising hiring as rising work. The matter count held flat (+2.1%), so a new partner competes for a steady pool of mandates rather than riding a wave. That argues for lateral partners who bring clients already in hand, and for associate hires that support an existing transactional partner instead of building a bench ahead of demand. In the Sartori & Partners lateral database, health care partner arrivals held flat (+6.7%), so the partner market is not getting easier to draw from.